AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RADIOPHARM THERANOSTICS LTD

0.032

+0.0026.67%

Volume:16.08M

Turnover:503.52K

Market Cap:74.69M

PE:-0.85

High:0.033

Open:0.030

Low:0.030

Close:0.030

Loading ...

Overview Company News Filings

BUZZ-Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus

BRIEF-Radiopharm Theranostics Says Lantheus Increases Shareholding In Co

Radiopharm Theranostics - Placement at a$0.060 per Share

THOMSON REUTERS

Radiopharm Theranostics Partners With Lantheus on Oncology Radiopharmaceuticals Development; Shares Up 9%

MT Newswires Live

Radiopharm Announces Strategic Co-Development Partnership With Lantheus for Australia

THOMSON REUTERS

BRIEF-Radiopharm Theranostics Announces Strategic Co-Development Partnership With Lantheus

BUZZ-Australia's Radiopharm Theranostics rises on partnership with Lantheus

Radiopharm Theranostics Ltd - to Receive up to $2 Mln in Milestone Payments

THOMSON REUTERS

Radiopharm Theranostics Ltd - Announces Strategic Co-Development Partnership With Lantheus

THOMSON REUTERS

Rad 202 Receives Approval to Start Phase 1 Therapeutic Trial

THOMSON REUTERS

ASX Small-Cap Stocks to Watch

MT Newswires Live

Radiopharm Theranostics Ltd-Rad 202 Receives Approval to Start Phase 1 Therapeutic Trial

THOMSON REUTERS

Radiopharm Theranostics Completes Preclinical Package for Radiotherapeutic Product; Shares Slump 17%

MT Newswires Live

Radiopharm Achieves Nasdaq Listing of American Depositary Shares

THOMSON REUTERS

BRIEF-Radiopharm Theranostics Achieves Nasdaq Listing Of American Depositary Shares

Radiopharm Theranostics Ltd - Achieves Nasdaq Listing of American Depositary Shares

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/RAD.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RAD.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.032,"timestamp":1741583520000,"preClose":0.03,"halted":0,"volume":16084721,"delay":0,"changeRate":0.066667,"change":0.002,"floatShares":1544866590,"shares":2333980142,"eps":-0.037714,"lyrEps":-0.124072,"pbRate":1.4,"amount":503521,"amplitude":0.1,"volumeRatio":0.829646,"dividePrice":0,"prevYearClose":0.024,"fiveDayClose":0.026,"twentyDayClose":0.025},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":1544866590,"roa":"-28.87%","roe":"-112.21%","lyrEps":-0.124072,"volumeRatio":0.829646,"shares":2333980142,"dividePrice":0,"high":0.033,"amplitude":0.1,"preClose":0.03,"low":0.03,"week52Low":0.021,"pbRate":"1.40","psRate":"172.97","week52High":0.067,"institutionHeld":0,"latestPrice":0.032,"committee":0.037075,"eps":-0.037714,"divideRate":0,"volume":16084721,"delay":0,"ttmEps":-0.037714,"open":0.03,"prevYearClose":0.024,"prevWeekClose":0.03,"prevMonthClose":0.026,"prevQuarterClose":0.024,"fiveDayClose":0.026,"twentyDayClose":0.025,"sixtyDayClose":0.033},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502079354","title":"BUZZ-Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus","url":"https://stock-news.laohu8.com/highlight/detail?id=2502079354","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502079354?lang=en_us&edition=fundamental","pubTime":"2025-01-10 07:47","pubTimestamp":1736466443,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus** Radiopharm Theranostics RAD.AX leaps as much as 50% to A$0.036; set for biggest ever intraday pct gain** Biopharma secures private placement agreement with Massachusetts-based Lantheus Holdings LNTH.O to raise $5 mln** Issue price of A$0.060 represents 150% premium to last close** Co earlier signed co-development deal with the NASDAQ-listed firm to develop biopharmaceuticals in Australia** Stock hits its highest level since Dec. 10, 2024** More than 12.9 mln shares traded, 1.2x the 30-day avg** RAD fell 67.6% in 2024 - third consecutive bear run since 2022  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nL4N3O5126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU","BK4198","BK4585","BK4588","LNTH"],"gpt_icon":0},{"id":"2502730020","title":"BRIEF-Radiopharm Theranostics Says Lantheus Increases Shareholding In Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2502730020","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502730020?lang=en_us&edition=fundamental","pubTime":"2025-01-10 06:09","pubTimestamp":1736460546,"startTime":"0","endTime":"0","summary":"Jan 10 (Reuters) - Radiopharm Theranostics Ltd   :   * LANTHEUS INCREASES SHAREHOLDING IN CO WITH A$8M PLACEMENT   * PLACEMENT AT A$0.060 PER SHARE Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4588","LNTH","BK4585","RAD.AU","BK7067"],"gpt_icon":0},{"id":"2502902073","title":"Radiopharm Theranostics - Placement at a$0.060 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2502902073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502902073?lang=en_us&edition=fundamental","pubTime":"2025-01-10 06:08","pubTimestamp":1736460485,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250109:nFWN3O50F3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"2495882826","title":"Radiopharm Theranostics Partners With Lantheus on Oncology Radiopharmaceuticals Development; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495882826","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495882826?lang=en_us&edition=fundamental","pubTime":"2024-12-31 08:12","pubTimestamp":1735603926,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics (ASX:RAD) partnered with Nasdaq-listed Lantheus to develop oncology radiopharmaceuticals in Australia, according to a Monday filing with the Australian bourse.The partnership w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4198","BK4585","LNTH","BK7067","XAO.AU","XJO.AU","RAD.AU","XKO.AU","BK4588"],"gpt_icon":0},{"id":"2495169541","title":"Radiopharm Announces Strategic Co-Development Partnership With Lantheus for Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2495169541","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495169541?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:00","pubTimestamp":1735563601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA7QZVBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"2495671551","title":"BRIEF-Radiopharm Theranostics Announces Strategic Co-Development Partnership With Lantheus","url":"https://stock-news.laohu8.com/highlight/detail?id=2495671551","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495671551?lang=en_us&edition=fundamental","pubTime":"2024-12-30 08:56","pubTimestamp":1735520183,"startTime":"0","endTime":"0","summary":"BRIEF-Radiopharm Theranostics Announces Strategic Co-Development Partnership With LantheusDec 30 (Reuters) - Radiopharm Theranostics Ltd RAD.AX:ANNOUNCES STRATEGIC CO-DEVELOPMENT PARTNERSHIP WITH LANT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NU009:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"2495559587","title":"BUZZ-Australia's Radiopharm Theranostics rises on partnership with Lantheus","url":"https://stock-news.laohu8.com/highlight/detail?id=2495559587","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495559587?lang=en_us&edition=fundamental","pubTime":"2024-12-30 08:33","pubTimestamp":1735518784,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Radiopharm Theranostics rises on partnership with Lantheus** Shares of clinical-stage biopharmaceutical firm Radiopharm Theranostics RAD.AX rise as much as 21.7% to A$0.028, their highest since Dec. 16** Co inks co-development deal to develop biopharmaceuticals with Massachusetts-based Lantheus LNTH.O in Australia** Deal includes basket clinical trial targeting multiple solid tumours** Co to receive up to $2 mln in milestone payments upon achieving key objectives, with the LNTH footing all costs** Including session's moves, stock trims YTD losses to 64.9% as of 2340 GMT  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nL4N3NU081:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","LNTH","RAD.AU","BK4198","BK4585","BK4588"],"gpt_icon":0},{"id":"2495374485","title":"Radiopharm Theranostics Ltd - to Receive up to $2 Mln in Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2495374485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495374485?lang=en_us&edition=fundamental","pubTime":"2024-12-30 06:02","pubTimestamp":1735509770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241229:nFWN3NU009:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"2495374125","title":"Radiopharm Theranostics Ltd - Announces Strategic Co-Development Partnership With Lantheus","url":"https://stock-news.laohu8.com/highlight/detail?id=2495374125","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495374125?lang=en_us&edition=fundamental","pubTime":"2024-12-30 06:02","pubTimestamp":1735509770,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241229:nFWN3NU009:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"2492448864","title":"Rad 202 Receives Approval to Start Phase 1 Therapeutic Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492448864?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:00","pubTimestamp":1734699600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nTUABRQG2V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"2492285436","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2492285436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492285436?lang=en_us&edition=fundamental","pubTime":"2024-12-20 07:46","pubTimestamp":1734651998,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Triton Minerals (ASX:TON)Triton Minerals received clearance from the Foreign Investme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PV1.AU","XKO.AU","XJO.AU","LAT.AU","RAD.AU","BK7067","BK7104","TON.AU","XAO.AU","BK7509","BK7072","BK7016","BK7095","VR1.AU"],"gpt_icon":0},{"id":"2492648277","title":"Radiopharm Theranostics Ltd-Rad 202 Receives Approval to Start Phase 1 Therapeutic Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492648277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492648277?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:51","pubTimestamp":1734645068,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUE8WPG9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"2490056300","title":"Radiopharm Theranostics Completes Preclinical Package for Radiotherapeutic Product; Shares Slump 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490056300","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490056300?lang=en_us&edition=fundamental","pubTime":"2024-12-10 12:24","pubTimestamp":1733804668,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  completed the preclinical package for its radiotherapeutic product 161 terbium-labeled RAD 402, or 161Tb-Rad 402, according to a Tuesday filing with the Australian bourse.Preclinical toxicology studies showed no adverse effects, while biodistribution reports showed minimal uptake in the kidney and bone marrow with high-prostate cancer tumor targeting in mice models, the filing said.The biopharmaceutical firm is expected to conduct its first-in-human trials for the product by the second half of 2025, per the filing.Company shares slumped 17% in recent Tuesday trade.Price : $0.03, Change: $-0.01, Percent Change: -17.07%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LU1043141123.HKD","BK4125","LU0345774631.USD","LU0426412945.USD","LU0994945656.USD","LU2238339852.HKD","AUD","LU0426417589.USD","RAD.AU"],"gpt_icon":0},{"id":"2486682931","title":"Radiopharm Achieves Nasdaq Listing of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2486682931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486682931?lang=en_us&edition=fundamental","pubTime":"2024-11-27 21:01","pubTimestamp":1732712488,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"2486985513","title":"BRIEF-Radiopharm Theranostics Achieves Nasdaq Listing Of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2486985513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486985513?lang=en_us&edition=fundamental","pubTime":"2024-11-27 06:55","pubTimestamp":1732661745,"startTime":"0","endTime":"0","summary":"Nov 27 (Reuters) - Radiopharm Theranostics Ltd   :   * ACHIEVES NASDAQ LISTING OF AMERICAN DEPOSITARY SHARESFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"2486834203","title":"Radiopharm Theranostics Ltd - Achieves Nasdaq Listing of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2486834203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486834203?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:23","pubTimestamp":1732656239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nFWN3MX0R4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD.AU","BK7067"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":2,"totalSize":45}]}}